1.Heterotopic ossification following femoral head replacement.
Sung Man ROWE ; Hyun Seon PARK ; Bong Woon KIM
The Journal of the Korean Orthopaedic Association 1991;26(4):1067-1072
No abstract available.
Head*
;
Ossification, Heterotopic*
2.The clinical and histopathological studies on ovarian tumors.
Sung woon CHANG ; Seon Kyung LEE ; Seoung Bo KIM ; Jae Hyun LEE ; Jung Eun MOK
Korean Journal of Obstetrics and Gynecology 1993;36(7):1073-1083
No abstract available.
3.A clinical analysis of surgical mortality.
Woon Yeon HONG ; Nam Cheon CHO ; Kwang Soo YOON ; Dae Sung KIM ; Byoung Seon RHOE ; Soo Yong KIM
Journal of the Korean Surgical Society 1993;45(5):854-861
No abstract available.
Mortality*
5.Effects of enamel matrix protein derivatives on the periodontal ligament like fibroblast and osteoblast like cells.
Dong Woon KIM ; Chin Hyung CHUNG ; Sung Bin LIM ; Seon Yle KO
The Journal of the Korean Academy of Periodontology 2003;33(2):225-246
Recent study on the enamel matrix derivatives explained on the effects of new bone and new attachment formation in infrabony pocket of periodontal defects. The purpose of this study was to investigate on the biological effects of enamel matrix derivatives to attachment, proliferation and activation of periodontal ligament and osteoblast cells. After treatment of osteoblast and PDL cells with various Emdogain concentration level(0.03microgram/ml, 3microgram/ml, 300 microgram/ml), activation of osteogenetic factor, calcified nodule formation and measuring alkaline phosphatase activity(ALP) were performed. 1. Both osteoblast and PDL cell showed increasing initial cell attachment with 300microgram/ml Emdogain concentration. 2. At the level of 300microgram/ml, accelerated proliferation of oseoblast and PDL cell was appeared. 3. As Emdogain's concentration increased, increased ALP activation of osteoblast was shown. In case of PDL cell, Emdogain increased ALP activation prominently at the level of 300microgram/ml. 4. No statistically significant activating change were founded at all of the concentrations of Emdogain on the activating of transcript factor Runx2 for differentiating osteoblast. 5. At the level of 300microgram/ml, calcified nodule formation was increased prominently to compare with other concentration. These results indicated that Emdogain should activate initial attachment, proliferation and activation, but not on Runx2 activation and can be used for useful tool of the treatment of periodontal tissue regeneration.
Alkaline Phosphatase
;
Dental Enamel*
;
Fibroblasts*
;
Osteoblasts*
;
Periodontal Ligament*
;
Regeneration
6.Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea.
Kyu Yeon HUR ; Jung Hee KIM ; Byung Joon KIM ; Min Seon KIM ; Eun Jig LEE ; Sung Woon KIM
Endocrinology and Metabolism 2015;30(1):7-18
Cushing's disease (CD) is a rare disorder characterized by the overproduction of adrenocorticotropic hormone due to a pituitary adenoma that ultimately stimulates excessive cortisol secretion from the adrenal glands. Prior to the detection of pituitary adenomas, various clinical signs of CD such as central obesity, moon face, hirsutism, and facial plethora are usually already present. Uncontrolled hypercortisolism is associated with metabolic, cardiovascular, and psychological disorders that result in increased mortality. Hence, the early detection and treatment of CD are not only important but mandatory. Because its clinical manifestations vary from patient to patient and are common in other obesity-related conditions, the precise diagnosis of CD can be problematic. Thus, the present set of guidelines was compiled by Korean experts in this field to assist clinicians with the screening, diagnoses, and treatment of patients with CD using currently available tests and treatment modalities.
Adrenal Glands
;
Adrenocorticotropic Hormone
;
Corticotropin-Releasing Hormone
;
Cushing Syndrome
;
Diagnosis*
;
Hirsutism
;
Humans
;
Hydrocortisone
;
Korea
;
Mass Screening
;
Mortality
;
Obesity, Abdominal
;
Petrosal Sinus Sampling
;
Pituitary ACTH Hypersecretion
;
Pituitary Neoplasms
7.Urinary polyamines in patients with gastrointestinal malignancy.
Seo Woon KIM ; Weon Seon HONG ; Bong Seog KIM ; Young Hyun LEE ; Hee Jun CHO ; Chang Min KIM ; Jhin Oh LEE ; Tae Woong KANG ; Seok Il HONG
Journal of the Korean Cancer Association 1991;23(1):76-82
No abstract available.
Humans
;
Polyamines*
9.Unveiling the Diversity of Hydnum in the Republic of Korea with One New Species, Hydnum paucispinum
Ji Seon KIM ; Wonjun LEE ; Changmu KIM ; Hanna PARK ; Chang Sun KIM ; Young Woon LIM
Mycobiology 2023;51(5):300-312
Hydnum is a genus of ectomycorrhizal fungi belonging to the Hydnaceae family. It is widely distributed across different regions of the world, including North America, Europe, and Asia; however, some of them showed disjunct distributions. In recent years, with the integration of molecular techniques, the taxonomy and classification of Hydnum have undergone several revisions and advancements. However, these changes have not yet been applied in the Republic of Korea. In this study, we conducted an integrated analysis combining the mor phological and molecular analyses of 30 specimens collected over a period of approximately 10 years in the Republic of Korea. For molecular analysis, the sequence data of the internal transcribed spacer (ITS) region, the large subunit of nuclear ribosomal RNA gene (nrLSU), and a portion of translation elongation factor 1-α (TEF1) were employed as molecular markers. Through this study, we identified eight species that had previously not been reported to occur in the Republic of Korea, including one new species, Hydnum paucispinum.A taxonomic key and detailed descriptions of the eight Hydnumm species are provided in this study.
10.The Efficacy of Endovascular Treatment for Deep Vein Thrombosis.
Seon Hee KIM ; Sung Woon CHUNG ; Chang Won KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2010;43(3):266-272
BACKGROUND: Deep vein thrombosis (DVT) is a serious disease that causes life-threatening pulmonary embolism and chronic venous insufficiency. Anticoagulation is the standard therapy for DVT. However, the results of standard anticoagulation for treating DVT have been disappointing, so endovascular treatment is commonly performed nowadays. The aim of this study was to evaluate the efficacy of an endovascular procedure for treating patients with DVT. MATERIAL AND METHOD: We retrospectively evaluated the clinical data of 29 DVT patients who underwent an endovascular procedure between December 2006 and July 2008. We compared the results of the 29 patients with the results of another 45 patients who were treated with only aspirin and heparin. RESULT: The patient's mean age was 55.4 years in the intervention group and 53.7 years in the control group. DVT occurred more frequently in the females. Catheter-directed thrombolysis was performed in 22 patients (75.8%). Aspiration thrombectomy was performed in 18 patients (62%) and a endovascular stent was placed in 25 patients (86.2%). Fifteen patients (51.7%) underwent percutaneous insertion of a retrievable IVC filter for the prevention of pulmonary embolism. In the control group, thirty nine patients (86.7%) were treated with low-molecular heparin, and seven patients (15.6%) who were contraindicated for warfarin were treated with aspirin. No bleeding complications occurred during thrombolysis or anticoagulation. We analyzed the statistical data according to recurrence of DVT and the incidence of post-thrombotic syndrome (PTS) during the follow-up period. The intervention group had a significantly lower incidence of PTS (p-value=0.008), but they had the same result as the control group for the recurrence of DVT. In addition, death from the DVT did not occur in the intervention group. Thus, we obtained better clinical outcomes in the intervention group as compared to those in the anticoagulation only group. CONCLUSION: Endovascular procedures are effective alternative modalities, as compared to systemic anticoagulation, for the treatment of DVT. But more studies are needed to determine the specific indications and to validate the long-term efficacy of endovascular procedures for the treatment of DVT.
Aspirin
;
Endovascular Procedures
;
Female
;
Follow-Up Studies
;
Hemorrhage
;
Heparin
;
Humans
;
Incidence
;
Pulmonary Embolism
;
Recurrence
;
Retrospective Studies
;
Stents
;
Thrombectomy
;
Thrombosis
;
Venous Insufficiency
;
Venous Thrombosis
;
Warfarin